Financials

  • Market Capitalization 307.43 M
  • Employee 117
  • Founded 1999
  • CEO N/A
  • Website www.niagenbioscience.com
  • Headquarter Delaware, United States
  • FIGI BBG000BG1J71
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
31.8
Rapporto prezzo/fatturato
4.2

Niagen Bioscience, Inc. - Common Stock

Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ.